The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: A simple and valid model of impulsive action using rats

Behavioural Pharmacology

Volumn 20, Issue 5-6, 2009, Pages 474-483

  Tsutsui Kimura, Iku ^a   Ohmura, Yu ^a   Izumi, Takeshi ^a   Yamaguchi, Taku ^a   Yoshida, Takayuki ^a   Yoshioka, Mitsuhiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atomoxetine; Fluvoxamine; Impulsive action; Impulsivity; Milnacipran; Nicotine; Three choice serial reaction time task

Indexed keywords

ATOMOXETINE; FLUVOXAMINE; MILNACIPRAN; NICOTINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; IMPULSIVENESS; MALE; NONHUMAN; RAT; RESPONSE TIME; TASK PERFORMANCE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; CYCLOPROPANES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUVOXAMINE; IMPULSIVE BEHAVIOR; MALE; NICOTINE; NICOTINIC AGONISTS; PROPYLAMINES; RATS; RATS, WISTAR; REACTION TIME; REPRODUCIBILITY OF RESULTS; SEROTONIN UPTAKE INHIBITORS;

EID: 70349690759     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283305e65     Document Type: Article

References (53)

1. Ansseau M, von Frenckell R, Martens C, de Wilde J, Botte L, Devoitille JM, et al. (1989). Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients. Psychopharmacology (Berl) 98:163-168. (Pubitemid 19137726)
2. Babinski LM, Hartsough CS, Lambert NM (1999). Childhood conduct problems, hyperactivity-impulsivity, and inattention as predictors of adult criminal activity. J Child Psychol Psychiatry 40:347-355.
3. Baca-Garcia E, Diaz-Sastre C, García Resa E, Blasco H, Braquehais Conesa D, Oquendo MA, et al. (2005). Suicide attempts and impulsivity. Eur Arch Psychiatry Clin Neurosci 255:152-156.
4. Bizarro L, Patel S, Murtagh C, Stolerman IP (2004). Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate. Behav Pharmacol 15:195-206.
5. Bizot JC, Thié bot MH, Le Bihan C, Soubrié P, Simon P (1988). Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats. Possible implication in the behavioral mechanism of action of antidepressants. J Pharmacol Exp Ther 246:1144-1151.
6. Bizot J, Le Bihan C, Puech AJ, Hamon M, Thiébot M (1999). Serotonin and tolerance to delay of reward in rats. Psychopharmacology (Berl) 146:400-412.
7. Blondeau C, Dellu-Hagedorn F (2007). Dimensional analysis of ADHD subtypes in rats. Biol Psychiatry 61:1340-1350.
8. Blondel A, Sanger DJ, Moser PC (2000). Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies. Psychopharmacology (Berl) 149:293-305.
9. Broersen LM, Uylings HB (1999). Visual attention task performance inWistar and Lister hooded rats: response inhibition deficits after medial prefrontal cortex lesions. Neuroscience 94:47-57.
10. Carboni E, Tanda GL, Frau R, Di Chiara G (1990). Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067-1070.
11. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983). Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction time task in rats; implications for theories of dorsal adrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361-380.
12. Clarke PB, Kumar R (1983). The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 78:329-337. (Pubitemid 13192204)
13. Corruble E, Hatem N, Damy C, Falissard B, Guelfi JD, Reynaud M, Hardy P (2003). Defense styles, impulsivity and suicide attempts in major depression. Psychopathology 36:279-284.
14. Coryell W, Young EA (2005). Clinical predictors of suicide in primary major depressive disorder. J Clin Psychiatry 66:412-417.
15. De Bruin NM, Fransen F, Duytschaever H, Grantham C, Megens AA (2006). Attentional performance of (C57BL/6Jx129Sv) F2 mice in the five-choice serial reaction time task. Physiol Behav 89:692-703.
16. Enticott PG, Ogloff JR, Bradshaw JL (2008). Response inhibition and impulsivity in schizophrenia. Psychiatry Res 157:251-254.
17. Evenden JL (1999a). Varieties of impulsivity. Psychopharmacology (Berl) 146:348-361.
18. Evenden JL (1999b). The pharmacology of impulsive behaviour in rats VII: the effects of serotonergic agonists and antagonists on responding under a discrimination task using unreliable visual stimuli. Psychopharmacology (Berl) 146:422-431.
19. Hahn B, Soaib M, Stolerman IP (2002). Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands. Psychopharmacology (Berl) 162:129-137.
20. Kako Y, Niwa Y, Toyomaki A, Yamanaka H, Kitagawa N, Denda K, Koyama T (2007). A case of adult attention-deficit/hyperactivity disorder alleviated by milnacipran. Prog Neuropsychopharmacol Biol Psychiatry 31:772-775.
21. Kessler RC, Borges G, Walters EE (1999). Prevalence of and risk factors for lifetime suicide attempts in the National comorbidity survey. Arch Gen Psychiatry 56:617-626.
22. Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T (2005). Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium. Eur J Pharmacol 516:219-226. (Pubitemid 40922741)
23. Koskinen T, Haapalinna A, SirviöJ (2003). Alpha-adrenoceptor- mediated modulation of 5-HT2 receptor agonist induced impulsive responding in a 5-choice serial reaction time task. Pharmacol Toxicol 92:214-225.
24. Loiseau F, Le Bihan C, Hamon M, Thié bot MH (2005). Antidepressant-like effects of agomelatine, melatonin and the NK1 receptor antagonist GR205171 in impulsive-related behaviour in rats. Psychopharmacology (Berl) 182:24-32.
25. Matsumoto M, Tachibana K, Togashi H, Tahara K, Kojima T,Yamaguchi T,Yoshioka M (2005). Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress. Psychopharmacology (Berl) 179:606-612.
26. McGirr A, Renaud J, Bureau A, Sequin M, Lesage A, Turecki G (2008). Impulsiveaggressive behaviours and completed suicide across the life cycle: a predisposition for younger age of suicide. Psychol Med 38:407-417.
27. Mirza NR, Stolerman IP (1998). Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology (Berl) 138:266-274.
28. Mitchell SH (1999). Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology (Berl) 146:455-464.
29. Ohmura Y, Takahashi T, Kitamura N (2005). Discounting delayed and probabilistic monetary gains and losses by smokers of cigarettes. Psychopharmacology (Berl) 182:508-515.
30. Ohmura Y, Yamaguchi T, Futami Y, Togashi H, Izumi T, Matsumoto M, et al. (2009). Corticotropin releasing factor enhances attentional function as assessed by the five-choice serial reaction time task in rats. Behav Brain Res 198:429-433.
31. Paris J (2005). The development of impulsivity and suicidality in borderline personality disorder. Dev Psychopathol 17:1091-1104. (Pubitemid 43362205)
32. Pattij T, Vanderschuren LJ (2008). The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 29:192-199.
33. Potvin S, Stip E, Roy JY (2003). Schizophrenia and addiction: an evaluation of the self-medication hypothesis. Encephale 29 (3 Pt 1):193-203.
34. Pozzi L, Invernizzi R, Cervo L, Vallebuona F, Samanin R (1994). Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J Neurochem 63:195-200.
35. Puumala T, Riekkinen P Sr, SirviöJ (1997). Modulation of vigilance and behavioral activation by alpha-1 adrenoceptors in the rat. Pharmacol Biochem Behav 56:705-712.
36. Raust A, Slama F, Mathieu F, Roy I, Chenu A, Koncke D, et al. (2006). Prefrontal cortex dysfunction in patients with suicidal behavior. Psychol Med 37:411-419.
37. Réné ric JP, Lucki I (1998). Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berl)136:190-197.
38. Robbins TW (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Ber) 163:362-380.
39. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, et al. (2008a). Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33:1028-1037.
40. Robinson ES, Dalley JW, Theobald DE, Glennon JC, Pezze MA, Murphy ER, Robbins TW (2008b). Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task. Neuropsychopharmacology 33:2398-2406.
41. Semenova S, Stolerman IP, Markou A (2007). Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats. Pharmacol Biochem Behav 87:360-368.
42. Sokolowski JD, Salamone JD (1994). Effects of dopamine depletions in the medial prefrontal cortex on DRL performance and motor activity in the rat. Brain Res 642:20-28.
43. Solanto MV (2002). Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 130:65-71.
44. Stahl SM, Grady MM, Moret C, Briley M (2005). SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10:732-747.
45. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Steinberg JL, Moeller FG (2005). Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry 162:1680-1687.
46. Tachibana K, Matsumoto M, Koseki H, Togashi H, Kojima T, Morimoto Y, Yoshioka M (2006). Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems. J Psychopharmacol 20:562-569.
47. Talpos JC, Wilkinson LS, Robbins TW (2006). A comparison of multiple 5-HT receptors in two tasks measuring impulsivity. J Psychopharmacol 20:47-58.
48. Van Gaalen MM, Brueqqeman RJ, Bronius PF, Schoffelmeer AN, Vanderschuren LJ (2006). Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl) 187:73-85.
49. Van Praag HM, Korf J (1974). Serotonin metabolism in depression: clinical application of the probenecid test. Int Pharmacopsychiatry 9:35-51.
50. Vaswani M, Linda FK, Ramesh S (2003). Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27:85-102.
51. Welzl H, Bättig K, Berz S (1990). Acute effects of nicotine injection into the nucleus accumbens on locomotor activity in nicotine-naive and nicotinetolerant rats. Pharmacol Biochem Behav 37:743-746.
52. Wilkinson RT (1963). Interaction of noise with knowledge of results and sleep deprivation. J Exp Psychol 66:332-337.
53. Yamamoto BK, Novotney S (1998). Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 71:274-280.